Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This Education Hub comparison sets a habit-focused app beside a prescription-first telehealth service. Browse the entire Peptides & GLP-1 library.
This is independent editorial writing. PlexusDx has no commercial relationship with Ro, receives no compensation for this review, and uses no affiliate links.
Ro and Noom start from different philosophies. Noom is known first as a behavior-change app, with medication offered as an add-on; Ro is a prescription-oriented telehealth service. Both now touch GLP-1 weight care. This comparison examines how coaching-led and prescription-led models differ, where they meet, and the genetic factor neither builds in.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Behavior-change app meets prescription telehealth
The core difference is philosophy. Noom (Noom, Inc.) grew from psychology-based habit coaching delivered through an app, later layering on a medication option. Ro (Roman Health) approaches weight care as a clinical, prescription-first service. One starts with behavior; the other starts with the script.
How Ro approaches weight care
Ro operates as subscription telehealth: online evaluation, clinician-issued prescription, and follow-up, dispensed through retail or compounding pharmacies as appropriate. Plans and pricing change, so review the current setup at Ro's official website.
Noom's app-first model with a medication add-on
Noom runs as an app-based subscription with an optional medication component. Its coaching content, medication access, and pricing vary by plan; confirm the current details at Noom's official website as of the date you read this.
Coaching and psychology versus pharmacology
Noom's roots are in daily logging, cognitive-behavioral prompts, and coaching aimed at habit change. That can complement medication but works through a different mechanism than a GLP-1. Ro's model centers the prescription and the clinical follow-up around it. A reader choosing between them is really choosing how much behavioral scaffolding they want alongside — or instead of — a drug.
Where the two overlap on GLP-1 access
Despite different starting points, both can lead to a GLP-1 prescription through licensed clinicians. When Noom's medication add-on is in play, the intake-review-prescribe-follow-up sequence resembles what a telehealth service like Ro runs. The behavioral wrapper differs; the clinical gate to medication is similar.
The trial evidence on the compounds
Whatever the app experience, the medication's effects come from the compound. GLP-1 receptor agonists — semaglutide, liraglutide, dulaglutide — and the dual GIP/GLP-1 agonist tirzepatide modulate appetite and satiety. STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide in obstructive sleep apnea, NEJM 2024) anchor the evidence, with results varying by dose, compound, and individual.
The genomic baseline no app measures
Neither habit tracking nor a prescription reads your inherited metabolism. A variant in GLP1R, the receptor every GLP-1 compound targets, sits with FTO in fat-mass biology, MC4R in satiety signaling, and TCF7L2 in glucose regulation. These pathway-level markers outline the terrain behind appetite and energy balance; they do not predict any specific medication's result.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any protocol begins, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across FTO and MC4R, and TCF7L2 — the test-before-you-invest step that gives a provider conversation a personal starting point.
Not affiliated: PlexusDx is not affiliated with Ro and has no commercial relationship with any company named in this article.
More from the PlexusDx library: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.
Disclaimer: This article is educational. PlexusDx is not affiliated with Ro and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Consider the alternative: see the Weight Management Protocols for semaglutide and tirzepatide with genetic context, or begin with the Precision Peptide Genetic Test.
Frequently Asked Questions
Is Noom a medication program or a coaching app?
Primarily a behavior-change app, Noom built its brand on psychology-based habit coaching and food logging, then added an optional medication component. Depending on the plan you select, you may use it purely for coaching or combine coaching with GLP-1 access. Check its current offerings before assuming which applies.
Can behavior coaching replace GLP-1 medication?
They work through different mechanisms and are not interchangeable. Coaching targets habits and daily choices, while a GLP-1 acts pharmacologically on appetite and satiety. Some people use them together. Whether either or both suits you is a clinical question best decided with a qualified healthcare provider.
Does the Precision Peptide Genetic Test include coaching?
No. It is a genetic analysis, not a coaching program, and it does not predict drug response. It reads pathway-level markers such as FTO, and MC4R that describe baseline metabolic biology — insight you can bring to any coaching or medication decision you make with a provider.
How does PlexusDx compare with Ro and Noom?
PlexusDx pairs semaglutide and tirzepatide protocols with the Precision Peptide Genetic Test. The differentiator is pathway-level genetic insight into FTO, MC4R — context that neither a coaching-first app nor a prescription-first telehealth service typically provides with the medication.
This article is part of the PlexusDx Education Hub. Browse more Peptides & GLP-1 education.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Brello Peptides: GLP-1 Offering, Dispensing Model, and Genetics
Ro Peptides: What the GLP-1 Offering Covers